Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Current Ratio
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Celgene Corp., current ratio, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in millions


Current Assets
Current assets exhibit a general upward trend from 973 million US dollars in 2005, peaking at 14,892 million in 2017. There is notable growth especially from 2011 to 2017, with values increasing from 4,353 million to 14,892 million. In 2018, a decline is observed where current assets decrease sharply to 9,067 million.
Current Liabilities
Current liabilities also show an overall increasing trend over the period. Starting at 136 million in 2005, they rise steadily to reach 4,057 million by 2018. Notable increments occur after 2009, with liabilities nearly quadrupling from 495 million in 2009 to over 2,987 million in 2017, followed by a further increase in 2018.
Current Ratio
The current ratio displays a fluctuating downward trend. Initially very high at 7.17 in 2005 and peaking at 9.64 in 2006, it steadily decreases over time, reflecting an increasing proportion of current liabilities relative to current assets. By 2018, the current ratio falls to 2.23, which indicates a reduced margin of liquidity compared to earlier years. Despite some intermittent increases, the ratio generally declined, particularly after 2010.
Overall Analysis
Over the analyzed period, the growth in current liabilities outpaced the growth in current assets in the latter years, which contributed to the decreased liquidity as measured by the current ratio. Although current assets increased significantly overall, the rise in liabilities has tempered the liquidity position. The sharp drop in current assets in 2018 combined with increased liabilities further diminished the current ratio to its lowest level observed in the period.

Comparison to Competitors

Celgene Corp., current ratio, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)

Celgene Corp., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)

Microsoft Excel

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)

Celgene Corp., current ratio, long-term trends, comparison to industry (health care)

Microsoft Excel

Based on: 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).